Activin inhibits telomerase activity in cancer.

[1]  Z. Tao,et al.  Strategies of treating cancer by cytokine regulation of chromosome end remodelling , 2010, Clinical and experimental pharmacology & physiology.

[2]  A. Shelling,et al.  Activin is a potent growth suppressor of epithelial ovarian cancer cells. , 2009, Cancer letters.

[3]  A. Pinto,et al.  Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. , 2008, Cancer research.

[4]  W. Duan,et al.  Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc* , 2008, Journal of Biological Chemistry.

[5]  C. Harley,et al.  Telomerase and cancer therapeutics , 2008, Nature Reviews Cancer.

[6]  Xiang-Jiao Yang,et al.  Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. , 2008, Cellular signalling.

[7]  Jun-Ping Liu,et al.  Mechanisms of Action of TGF‐β in Cancer , 2007 .

[8]  Jun-Ping Liu,et al.  Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene. , 2007, Annals of the New York Academy of Sciences.

[9]  T. Woodruff,et al.  Activin and estrogen crosstalk regulates transcription in human breast cancer cells. , 2007, Endocrine-related cancer.

[10]  I. Treilleux,et al.  Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth. , 2007, Cancer research.

[11]  Wendy S. Wright,et al.  (www.interscience.wiley.com) DOI: 10.1002/path.2090 Review Article Hallmarks of telomeres in ageing research , 2022 .

[12]  Dakang Xu,et al.  Transforming Growth Factor (cid:1) Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene , 2022 .

[13]  J. Shay,et al.  Telomerase therapeutics for cancer: challenges and new directions , 2006, Nature Reviews Drug Discovery.

[14]  Xueyan Duan,et al.  PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling , 2006, Cell.

[15]  Dakang Xu,et al.  TGF-beta and cancer: is Smad3 a repressor of hTERT gene? , 2006, Cell research.

[16]  Ekaterini Panopoulou,et al.  Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms. , 2005, Cancer research.

[17]  S. Choe,et al.  Activins and Inhibins and Their Signaling , 2004, Annals of the New York Academy of Sciences.

[18]  Jing Yin,et al.  Activin Type II Receptor Restoration in ACVR2-Deficient Colon Cancer Cells Induces Transforming Growth Factor-β Response Pathway Genes , 2004, Cancer Research.

[19]  K. Tsuchida,et al.  Novel factors in regulation of activin signaling , 2004, Molecular and Cellular Endocrinology.

[20]  Mohammad Zafari,et al.  Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. , 2003, The Journal of clinical investigation.

[21]  A. Rademaker,et al.  Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. , 2003, Cancer research.

[22]  B. Vogelstein,et al.  Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. , 2003, Cancer research.

[23]  Nikita Popov,et al.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Hruban,et al.  ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Montgomery,et al.  すい臓癌におけるACVR1B(ALK4、1B型アクチビン受容体)遺伝子の突然変異 , 2001 .

[26]  P. Fowler,et al.  Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. , 1996, The Journal of clinical endocrinology and metabolism.

[27]  原田 和代.  Serum immunoreactive activin A levels in normal subjects and patients with various diseases , 1996 .

[28]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.